- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 5/36 - Antigestagens
Patent holdings for IPC class A61P 5/36
Total number of patents in this class: 30
10-year publication summary
|
2
|
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer Schering Pharma AG | 311 |
4 |
| Bayer Pharma AG | 1010 |
4 |
| ASKA Pharmaceutical Co., Ltd. | 96 |
3 |
| Repros Therapeutics Inc. | 35 |
3 |
| Evestra, Inc. | 33 |
2 |
| PregLem SA | 17 |
2 |
| Richter Gedeon Nyrt. | 1702 |
2 |
| Bayer Intellectual Property GmbH | 2357 |
1 |
| Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China | 173 |
1 |
| Laboratoire Hra-pharma | 155 |
1 |
| MSD Oss B.V. | 12 |
1 |
| N.V. Organon | 525 |
1 |
| Parthenogen Sagl | 9 |
1 |
| Solvay Pharmaceuticals GmbH | 7 |
1 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3007 |
1 |
| Vancouver Biotech Ltd. | 14 |
1 |
| Crystal Pharmaceutical (Suzhou) Co., Ltd. | 120 |
1 |
| Other owners | 0 |